Premium
Commentary: infliximab or adalimumab in C rohn's disease?
Author(s) -
Sprakes M. B.,
Hamlin P. J.
Publication year - 2012
Publication title -
alimentary pharmacology and therapeutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.308
H-Index - 177
eISSN - 1365-2036
pISSN - 0269-2813
DOI - 10.1111/j.1365-2036.2012.05167.x
Subject(s) - medicine , infliximab , adalimumab , regimen , crohn's disease , placebo , surgery , adverse effect , disease , pathology , alternative medicine